Hjem › Overvægt › New York › Rochester
Overvægt kliniske forsøg i Rochester, NY
14 studier for Overvægt søger deltagere på steder i og omkring Rochester (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 2
- Rochester Clinical Research /ID# 282484, Rochester
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RekruttererFase 2
- Rochester Clinical Research, Rochester
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekruttererFase 3
- Rochester Clinical Research, LLC, Rochester
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekruttererFase 3
- Rochester Clinical Research, Rochester
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RekruttererFase 3
- Rochester Clinical Research, LLC, Rochester
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RekruttererFase 3
- Rochester Clinical Research, LLC, Rochester
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RekruttererFase 2
- Rochester Clinical Research, LLC, Rochester
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RekruttererFase 2
- Rochester Clinical Research, LLC, Rochester
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RekruttererFase 3
- Rochester Clinical Research, Rochester
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
RekruttererFase 3
- Kailera Clinical Site, Rochester
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RekruttererFase 3
- Rochester Clinical Research, Rochester
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruttererFase 3
- University of Rochester, Rochester
Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
RekruttererObservationsstudie
- University of Rochester Medical Center, Rochester
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Eastman Institute for Oral Health, University of Rochester, Rochester
Overvægt forsøg i andre byer
- Houston, TX43 studier
- Chicago, IL41 studier
- New York City, NY40 studier
- San Antonio, TX40 studier
- Washington, DC33 studier
- Orlando, FL31 studier
- Dallas, TX30 studier
- Boston, MA28 studier
- Las Vegas, NV27 studier
- Miami, FL27 studier
- Baltimore, MD25 studier
- Jacksonville, FL25 studier
Andre studier i Rochester
- Akut myeloid leukæmi16 studier
- Lungecancer15 studier
- Brystkræft15 studier
- Kræft (alle typer)14 studier
- Ikke-småcellet lungecancer13 studier
- Overvægt13 studier
- Prostatakræft10 studier
- Multipelt myelom8 studier
- Metastatisk cancer8 studier
- Bugspytkirtelkræft7 studier
- Myotonisk dystrofi7 studier
- Blærecancer7 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.